New robot arm takes on cancer surgery – first safety check begins
NCT ID NCT07632638
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study will test a new robotic surgery platform called RonovoTM in 40 adults with cancer who need elective surgery. The robot helps surgeons perform minimally invasive procedures in digestive, thoracic, urology, and gynecology areas. Researchers will track complications, technical failures, and how well the surgery goes to see if the platform is safe and effective.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
RonovoTM Robotic Surgical Platform
What this could lead to
If successful, this could provide safety data to support regulatory approval of a new robotic surgery tool for cancer operations in Latin America.
What could go wrong
This is a small, early-stage registry with only 40 participants and no comparison group, so results may not apply broadly. Technical failures or complications could occur.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Instituto do Câncer do Estado de São Paulo - ICESP
São Paulo, São Paulo, 05403-010, Brazil
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact